Birgitta Agerberth

13.4k total citations · 4 hit papers
111 papers, 10.8k citations indexed

About

Birgitta Agerberth is a scholar working on Microbiology, Immunology and Molecular Biology. According to data from OpenAlex, Birgitta Agerberth has authored 111 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Microbiology, 51 papers in Immunology and 44 papers in Molecular Biology. Recurrent topics in Birgitta Agerberth's work include Antimicrobial Peptides and Activities (77 papers), Immune Response and Inflammation (34 papers) and Pediatric health and respiratory diseases (21 papers). Birgitta Agerberth is often cited by papers focused on Antimicrobial Peptides and Activities (77 papers), Immune Response and Inflammation (34 papers) and Pediatric health and respiratory diseases (21 papers). Birgitta Agerberth collaborates with scholars based in Sweden, Iceland and Bangladesh. Birgitta Agerberth's co-authors include Guðmundur H. Guðmundsson, Peter Bergman, Hans Jörnvall, Hans Wigzell, Jan Johansson, Berit Olsson, Tomas Bergman, Lennart Lindbom, Martı́n E. Rottenberg and Yechiel Shai and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Birgitta Agerberth

110 papers receiving 10.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders

1997 643 citations Birgitta Agerberth, Hans Wigzell et al. Journal of Biological Chemistry profile →
The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations

2000 615 citations Birgitta Agerberth, Berit Olsson et al. profile →
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37

1998 541 citations Jan Johansson, Guðmundur H. Guðmundsson et al. Journal of Biological Chemistry profile →
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

2006 505 citations Milan Chromek, Peter Bergman et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgitta Agerberth Sweden	51	6.1k	4.3k	4.2k	1.1k	1.1k	111	10.8k
Guðmundur H. Guðmundsson Sweden	51	5.9k 1.0×	4.2k 1.0×	3.9k 0.9×	930 0.8×	1.1k 1.0×	121	10.1k
Jürgen Harder Germany	48	4.8k 0.8×	3.9k 0.9×	3.9k 0.9×	867 0.8×	844 0.8×	125	10.1k
De Yang United States	53	5.7k 0.9×	4.7k 1.1×	7.0k 1.7×	1.1k 1.0×	921 0.9×	134	13.2k
Jens‐Michael Schröder Germany	51	4.8k 0.8×	3.7k 0.9×	5.7k 1.4×	999 0.9×	898 0.8×	134	12.7k
André J. Ouellette United States	52	5.0k 0.8×	5.0k 1.2×	3.0k 0.7×	667 0.6×	861 0.8×	141	9.9k
Ole E. Sørensen Sweden	50	3.2k 0.5×	2.8k 0.7×	3.9k 0.9×	894 0.8×	575 0.5×	98	8.8k
Gill Diamond United States	41	4.7k 0.8×	3.0k 0.7×	3.1k 0.8×	643 0.6×	747 0.7×	93	7.6k
Michael E. Selsted United States	66	11.9k 2.0×	9.3k 2.1×	6.0k 1.4×	1.2k 1.1×	1.3k 1.2×	141	17.0k
Donald J. Davidson United Kingdom	45	4.0k 0.7×	2.8k 0.6×	3.0k 0.7×	947 0.8×	692 0.7×	92	7.8k
Dawn M. E. Bowdish Canada	48	2.7k 0.4×	3.1k 0.7×	3.5k 0.8×	1.3k 1.2×	636 0.6×	168	8.8k

Countries citing papers authored by Birgitta Agerberth

Since Specialization

Citations

This map shows the geographic impact of Birgitta Agerberth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitta Agerberth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitta Agerberth more than expected).

Fields of papers citing papers by Birgitta Agerberth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitta Agerberth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitta Agerberth. The network helps show where Birgitta Agerberth may publish in the future.

Co-authorship network of co-authors of Birgitta Agerberth

This figure shows the co-authorship network connecting the top 25 collaborators of Birgitta Agerberth. A scholar is included among the top collaborators of Birgitta Agerberth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitta Agerberth. Birgitta Agerberth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rekha, Rokeya Sultana, Avinash Padhi, Ákos Végvári, et al.. (2024). The di-leucine motif in the host defense peptide LL-37 is essential for initiation of autophagy in human macrophages. Cell Reports. 44(1). 115031–115031. 3 indexed citations

Ren, Zhengnan, Li‐Long Pan, Yi‐Wen Huang, et al.. (2021). Gut microbiota‐CRAMP axis shapes intestinal barrier function and immune responses in dietary gluten‐induced enteropathy. EMBO Molecular Medicine. 13(8). e14059–e14059. 23 indexed citations

Mily, Akhirunnesa, Protim Sarker, Delwar Hossain, et al.. (2020). Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes. BMC Infectious Diseases. 20(1). 933–933. 13 indexed citations

Miraglia, Erica, Katarina Johansson, Elias S.J. Arnér, et al.. (2016). Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors. Scientific Reports. 6(1). 33274–33274. 42 indexed citations

Kulkarni, Nikhil N, Zhiqian Yi, Steinunn Guðmundsdóttir, et al.. (2015). Glucocorticoid dexamethasone down-regulates basal and vitamin D3 induced cathelicidin expression in human monocytes and bronchial epithelial cell line. Immunobiology. 221(2). 245–252. 20 indexed citations

Cederlund, Andreas, et al.. (2013). Label-Free Quantitative Mass Spectrometry Reveals Novel Pathways Involved in LL-37 Expression. Journal of Innate Immunity. 6(3). 365–376. 9 indexed citations

Raqib, Rubhana, Protim Sarker, Akhirunnesa Mily, et al.. (2012). Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. BMC Infectious Diseases. 12(1). 111–111. 76 indexed citations

Guðmundsson, Guðmundur H., Peter Bergman, Jan Andersson, Rubhana Raqib, & Birgitta Agerberth. (2010). Battle and balance at mucosal surfaces – The story of Shigella and antimicrobial peptides. Biochemical and Biophysical Research Communications. 396(1). 116–119. 25 indexed citations

Tollin, Maria, Eduardo Rodrı́guez, Bjarki Jóhannesson, et al.. (2008). PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Molecular Immunology. 45(15). 3947–3955. 68 indexed citations

10.

Chromek, Milan, Peter Bergman, László Kovács, et al.. (2006). The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nature Medicine. 12(6). 636–641. 505 indexed citations breakdown →

11.

Johansson, Linda, Anne Rytkönen, Hong Wan, et al.. (2005). Human-Like Immune Responses in CD46 Transgenic Mice. The Journal of Immunology. 175(1). 433–440. 36 indexed citations

12.

Starner, Timothy D., Birgitta Agerberth, Guðmundur H. Guðmundsson, & Paul B. McCray. (2005). Expression and Activity of β-Defensins and LL-37 in the Developing Human Lung. The Journal of Immunology. 174(3). 1608–1615. 96 indexed citations

13.

Bergsson, Gudmundur, Birgitta Agerberth, Hans Jörnvall, & Guðmundur H. Guðmundsson. (2005). Isolation and identification of antimicrobial components from the epidermal mucus of Atlantic cod (Gadus morhua). FEBS Journal. 272(19). 4960–4969. 115 indexed citations

14.

Johansson, Linda, Anne Rytkönen, Peter Bergman, et al.. (2003). CD46 in Meningococcal Disease. Science. 301(5631). 373–375. 136 indexed citations

15.

Wang, Yuqin, William J. Griffiths, Hans Jörnvall, Birgitta Agerberth, & Jan Johansson. (2002). Antibacterial peptides in stimulated human granulocytes. European Journal of Biochemistry. 269(2). 512–518. 33 indexed citations

16.

Dorschner, Robert A., Takaaki Ohtake, Jennifer A. Rudisill, et al.. (2001). Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A Streptococcus. Journal of Investigative Dermatology. 117(1). 91–97. 445 indexed citations

17.

Agerberth, Birgitta, Johan Grünewald, Esmeralda Castaños‐Vélez, et al.. (1999). Antibacterial Components in Bronchoalveolar Lavage Fluid from Healthy Individuals and Sarcoidosis Patients. American Journal of Respiratory and Critical Care Medicine. 160(1). 283–290. 144 indexed citations

18.

Johansson, Jan, Guðmundur H. Guðmundsson, Martı́n E. Rottenberg, Kurt D. Berndt, & Birgitta Agerberth. (1998). Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37. Journal of Biological Chemistry. 273(6). 3718–3724. 541 indexed citations breakdown →

19.

Agerberth, Birgitta, et al.. (1991). Pancreatic secretory trypsin inhibitor (PSTI) isolated from pig intestine Influence on insulin and somatostatin release. FEBS Letters. 281(1-2). 227–230. 5 indexed citations

20.

Agerberth, Birgitta, Jong‐Youn LEE, Tomas Bergman, et al.. (1991). Amino acid sequence of PR‐39. European Journal of Biochemistry. 202(3). 849–854. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact